
Shares of Kleenex tissue maker Kimberly-Clark KMB.N down 1.1% at $129.95 premarket
Co's Q4 adjusted EPS of $1.50 narrowly misses estimates of $1.51 - data compiled by LSEG
Q4 revenue falls 1.8% to $4.93 billion, but beats estimates of $4.86 billion
Co also sees adjusted EPS for fiscal 2025 to rise by mid-to-high single-digits compared with estimates of 3.2% increase
KMB rose ~8% in 2024